Diabetes No Yes Tape Adherent No Yes Back No Yes. Cancer No Yes Aspirin No Yes Teeth No Yes Yes Have you ever taken insulin or tablets for diabetes No Yes …
ECONOMIC OUTCOMES ASSOCIATED WITH SWITCHING TO INSULIN PEN THERAPY IN
MEDICAID TYPE 2 DIABETES PATIENTS: A RETROSPECTIVE DATABASE ANALYSIS
Manjiri D Pawaskar, MS1, Rajesh Balkrishnan, PhD1, Fabian T Camacho, MS2
and Roger T Anderson, PhD2
1 Department of Pharmacy Practice and Administration, College of Pharmacy,
Ohio State University College of Pharmacy, Columbus, Ohio, USA
2 Division of Public Health Sciences, Wake Forest University School of
Medicine, Winston Salem, North Carolina, USA
Objective: Outcomes in patients with type 2 diabetes may vary according to
the type of pharmacotherapy The study examined the differences in
medication adherence and the total health care costs in patients with type
2 diabetes who switched from oral anti-diabetic medications OAD to
insulin vial/syringe therapy vs those who converted from OAD to insulin
pen therapy
Methods: The study comprised of patients with type 2 diabetes who were
enrolled in the North Carolina Medicaid program from September 24, 2001 to
July 18, 2006 Patients who switched from OAD to syringe n1162 were
pair-matched with those who switched from OAD to pen group by age,
total
health care costs and diabetes related costs All included patients had
complete enrollment for 24 months of follow up Multiple linear regression
models were used to predict the impact switching therapies on individual
outcomes ie total health care costs and medication adherence for each
cohort using propensity scores as covariates The adjusted means were
calculated to determine the group differences across different outcomes
Results: Medication adherence was comparable for patients who switched to
pen vs syringe 53 vs 50 respectively The total health care costs for
patients on pen therapy was significantly lower than those on syringe
insulin 14,85742 vs 31,76478 respectively; p 001 considerable
costs savings with pen therapy were reflected in hospital costs 1,19593
vs 4,96531 respectively; p001, clinic costs 1,08680 vs 3,68517
respectively; p005, diabetes related costs 7,32437 vs 13,76221
respectively; p001 and outpatient costs 7,79598 vs 13,10351
respectively; p001
Conclusion: Even though, medication adherence was similar in both the
groups, switching to pen therapy reflected significant reduction in
health
care services utilizations and associated costs Health care professionals
and policy makers should consider initiating pen therapy in patients who
fail to respond to OADs
Source:fredonia.edu
